Silicon Valley billionaires are obsessed with 'reprogramming' their bodies for longevity. The first human trial suggests they may be onto something.

Silicon Valley billionaires are obsessed with 'reprogramming' their bodies for longevity. The first human trial suggests they may be onto something. — Live Feedhttps://www.live-feeds.com/feed/silicon-valley-billionaires-are-obsessed-with-reprogramming-their-bodies-for-longevity-the-first-human-trial-suggests-thContinuously updated, source-cited coverage. First Human Trial Suggests Cellular Rejuvenation Is Possiblehttps://www.live-feeds.com/feed/silicon-valley-billionaires-are-obsessed-with-reprogramming-their-bodies-for-longevity-the-first-human-trial-suggests-thhttps://www.live-feeds.com/feed/silicon-valley-billionaires-are-obsessed-with-reprogramming-their-bodies-for-longevity-the-first-human-trial-suggests-th#u116426Sun, 11 Oct 2026 14:31:38 +0000Silicon Valley billionaires are pursuing body reprogramming techniques for longevity, and the first human trial indicates these methods may actually work. Life Biosciences released first-in-human data from an ongoing Phase 1 clinical trial evaluating the epigenetic restoration therapy known as ER-100 in optic neuropathies and glaucoma. Researchers and technology figures have long focused on anti-aging interventions, but this study marks a concrete milestone by reaching human trials. Eye cells may have been successfully rejuvenated for the first time in people, bringing cellular reprogramming c